| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aytu Biopharma, Inc (AYTU) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. AYTU is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.82M | $12.04M | - | |
| CEO | 184.7K | $461.8K | - | |
| Other | 61.6K | $153.9K | - | |
| Other | 36.1K | $90.3K | - | |
| CFO | 32.2K | $80.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 6, 2016 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 250,000 | $0.40 | $100,000.00 | +162.5% | |
| May 6, 2016 | Disbrow Jarrett | Chief Operating Officer | Buy | 250,000 | $0.40 | $100,000.00 | +162.5% | |
| May 6, 2016 | Dockery Carl | Director | Buy | 5,000,000 | $0.40 | $2,000,000.00 | +10,506% | |
| Jan 20, 2016 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 153,846 | $0.65 | $99,999.90 | New | |
| Jan 20, 2016 | Disbrow Jarrett | Chief Operating Officer | Buy | 153,846 | $0.65 | $99,999.90 | New |